Singapore markets closed

SpringWorks Therapeutics, Inc. (SWTX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
25.00-1.15 (-4.40%)
At close: 04:00PM EDT
25.08 +0.08 (+0.32%)
After hours: 07:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.50B
Enterprise value 1.17B
Trailing P/E 21.09
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)4.62
Enterprise value/revenue 64.18
Enterprise value/EBITDA -5.18

Trading information

Stock price history

Beta (5Y monthly) 0.84
52-week change 3-63.90%
S&P500 52-week change 3-16.88%
52-week high 377.70
52-week low 313.60
50-day moving average 328.98
200-day moving average 343.35

Share statistics

Avg vol (3-month) 3921.44k
Avg vol (10-day) 31.25M
Shares outstanding 560.14M
Implied shares outstanding 6N/A
Float 828.39M
% held by insiders 110.30%
% held by institutions 1121.93%
Shares short (30 Aug 2022) 48.9M
Short ratio (30 Aug 2022) 49.05
Short % of float (30 Aug 2022) 431.30%
Short % of shares outstanding (30 Aug 2022) 417.99%
Shares short (prior month 28 Jul 2022) 412.26M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-32.04%
Return on equity (ttm)-55.44%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -226.61M
Net income avi to common (ttm)-227.96M
Diluted EPS (ttm)-4.23
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)334.54M
Total cash per share (mrq)6.81
Total debt (mrq)5.78M
Total debt/equity (mrq)1.77
Current ratio (mrq)9.80
Book value per share (mrq)6.63

Cash flow statement

Operating cash flow (ttm)-161M
Levered free cash flow (ttm)-80.66M